NEW ORLEANS – HHS Secretary Alex Azar highlighted the symbiosis of the generic industry and the Trump Administration in his address at the Association for Accessible Medicines annual meeting here on Feb. 6. Just as the generic industry needs policy reforms to strengthen its business model, the Trump administration needs a strong generic industry to help achieve its goal of lowering list prices for drugs.
Azar didn't make that connection explicitly, but he noted "two of the many ways we’re looking to address situations
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?